MRM Health, a clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and immuno-oncology, has announced its collaboration with Professor Emile ...

JHU083 reduced tumour growth and triggered tumour cell death in mice Researchers from the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery have revealed that a novel therapy can ...

A British inquiry into the use of chemotherapy to treat seriously ill cancer patients has found the treatment caused or hastened death in 27% of cases. A British inquiry into the use of chemotherapy ...

Foundation’s test to be used in Oxford-led blood biomarker trial The Food for the Brain Foundation’s Cognitive Function Test is set to play a central role in the UK-based ‘READ OUT’ trial, which is ...

SMC approves targeted therapy for patients with EGFR exon 20 insertion mutations Johnson & Johnson has welcomed the decision by the Scottish Medicines Consortium (SMC) to accept Rybrevant (amivantamab ...

Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower pharmaceutical R&D costs through efficient drug discovery, optimised clinical trials, ...

US$5m payment from Bristol Myers Squibb marks progress in protein degradation partnership Evotec has received a US$5m milestone payment from Bristol Myers Squibb following the US Food and Drug ...

More than 37 million adults in the US are affected by migraine The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital therapeutic for the ...

Santhera Pharmaceuticals has announced positive topline results from a long-term analysis of AGAMREE (vamorolone) in patients with Duchenne muscular dystrophy (DMD), including first data from the ...

Evotec SE has announced a $25m milestone payment from Bristol Myers Squibb, recognising scientific progress made within their strategic neuroscience partnership. The funds will support continued ...

New MHRA–FDA collaboration aims to boost patient access and AI safety Patients in the UK are set to benefit from a strengthened partnership between the Medicines and Healthcare products Regulatory ...

New consultancy aims to deliver personalised senior expertise in healthcare communications Miranda Dini has announced the launch of GOLD Strategy & Communications, a global healthcare consultancy ...